Results 141 to 150 of about 253,218 (253)

A Registry-Based Perspective of Interventional Clinical Trials for Duchenne Muscular Dystrophy. [PDF]

Cureus
Chaudhary JH, Chacko JO, Susarla V, Kashyap Peraboina SS, Sen S.   +4 more
europepmc   +1 more source

Pharmacotherapy of Duchenne Muscular Dystrophy (DMD)

Duchenne Muscular Dystrophy (DMD) is a severe, progressive neuromuscular disorder caused by mutations in the DMD gene, leading to the absence of functional dystrophin protein.
Poornachandran, Deepti Nirja
core  

Echocardiography in duchenne muscular dystrophy: a call for consistency and standardisation of reporting. [PDF]

Echo Res Pract
Williams L, Bennett S, Atkinson C, Augustine DX, Bland M, Grant H, Hobday J, Johnson A, Kadhim K, Kuhwald L, Bettolo CM, Kerr A, Oxborough D, Ring L, Robinson S, Sopala J, Turner C, Villa C, Guglieri M, Bourke J, Coats C.   +20 more
europepmc   +1 more source

Duchenne muscular dystrophy: from gene to gene-ius therapies. [PDF]

Skelet Muscle
Muchir A, Musaro A, Chamberlain J.
europepmc   +1 more source

Noncompaction in Duchenne Muscular Dystrophy

Internal Medicine, 2016
Finsterer, Josef, Zarrouk-Mahjoub, Sinda
openaire   +6 more sources

Duchenne Muscular Dystrophy Under Three Years of Age. [PDF]

Children (Basel)
Coşkun AN, Topaloğlu H.
europepmc   +1 more source

Current and prospective treatment of Duchenne Muscular Dystrophy

Duchenne muscular dystrophy (DMD) is a serious condition of genetic origin that is passed down in the X-linked manner and that mainly afflicts boys. It is the result of a steady muscle tissue degeneration caused by mutations in the dystrophin gene on the
Rodriguez, Isaac
core  

Bridging Duchenne muscular dystrophy therapy from rhesus monkeys to patients. [PDF]

Clin Transl Med
Guo W, Ji W, Chen Y.
europepmc   +1 more source

Basal Energetics and Phosphocreatine Recovery Kinetics in Ambulatory Boys With Duchenne Muscular Dystrophy. [PDF]

NMR Biomed
Awale PP, Lopez C, Taivassalo T, Vandenborne K, Walter GA, Forbes SC.   +5 more
europepmc   +1 more source

Role of Finerenone in Duchenne Muscular Dystrophy in a 45-Year-Old Man: Outcome and Brief Review. [PDF]

JACC Case Rep
Hillyer J, Jefferies JL, Silver MA.
europepmc   +1 more source